BCL2 and colorectal cancer: Several clinical and experimental studies have shown that the activation of the Akt/ ERK1/2 pathways directly regulates P-gp, Bcl-2, and CXCR4 in colorectal cancer MDR cells associated with many physiologic and pathologic processes involving inflammation[14–15].